Implantable Cardioverter Debrillator Practices
and Costs at an Academic Medical Center
BRIAN OLSHANSKY, M.D., DEBORAH LOOTS, B.S.*
and MARY MCGRORY-USSET, M.B.A.*
From Loyola University Medical Center, Maywood, Illinois; and *Medtronic, Inc., Minneapolis, Minnesota
ICD Practices and Costs. This study addresses current costs of implanting implantable
cardioverter debrillators (ICDs) at one large medical center and documents actual costs using two
methodologies. To determine the actual cost of ICD therapy, we studied all ICD implants performed
in the procedure room (similar to an electrophysiology laboratory) who met accepted secondary
prevention (AVID) indications for a 1-year period at Loyola University Medical Center. The study
period coincided with the facility’s shift of this procedure out of the operating room to a procedure
room. Costs were analyzed two ways: a cost-based analysis and a cost-to-charge ratio analysis based
on the facility’s Medicare Cost Report. Twenty-four patients (14 inpatients and 10 outpatients) met
the study inclusion criteria. Length of stay averaged 5.8 days for inpatients and 1.1 days for
outpatients. In the cost-based analysis, the mean costs of the ICD implant (device, implant proce-
dure, and preimplant and postimplant stay) were $33,509 for inpatient and $28,078 for outpatient
implants. In the cost-to-charge ratio analysis, the mean costs for the inpatient hospitalization were
$35,623. This is one of the rst studies to document cost of ICD therapy and may serve as a
benchmark for other facilities. (J Cardiovasc Electrophysiol, Vol. 12, pp. 162-166, February 2001)
implantable cardioverter debrillator, implantable cardioverter debrillator implant, hospital costs,
cost analysis, inpatient and outpatient settings, AVID trial
Introduction
Both implantable cardioverter debrillator (ICD)
technology and physician practices have changed con-
siderably since the rst human implant in 1980 at the
Johns Hopkins University in Baltimore, Maryland.
1
Early ICDs were large and required a thoracotomy and
general anesthesia for the placement of patches and wires
on the outside of the heart. Implant of these early devices
typically required a 3- to 4-week hospitalization and the
costs were very high.
2
Decreased device size and the
development of leads that could be implanted trans-
venously have simplied the implant procedure. Because
today’s ICDs are implanted in a pectoral location using
local anesthesia or conscious sedation, procedures are
done more quickly and reduce stafng needs. The length
of the hospitalization also has decreased considerably,
with some patients being implanted in an outpatient
setting.
Loyola University Medical Center in Maywood, Illi-
nois, made a policy decision to move nearly all ICD
implants from the operating room to a less costly proce-
dure room in 1998 to deliver ICD implant care more
efciently. This study documents ICD implant practices
and resulting actual costs at that academic medical cen-
ter, providing a benchmark against which other facilities
can measure their own results.
Methods
To establish the actual cost of ICD therapy at an
academic medical center, 24 patients were selected pro-
spectively from 59 consecutive patients who underwent
initial ICD implantation at Loyola University Medical
Center for a 1-year period beginning April 1, 1998.
Enrolled patients were required to meet the study selec-
tion criteria used for the AVID trial
3
and to have their
implant performed in the procedure room rather than the
operating room (Table 1). This latter criterion was in-
tended to focus on costs and practices associated with the
emerging trend of performing implants in procedure
rooms or electrophysiology (EP) labs. Twenty of the
original 59 initial implant patients failed to meet the
AVID inclusion/exclusion criteria. Fifteen patients did
Research data collection and manuscript preparation were funded, in
part, by Medtronic, Inc.
Address for correspondence: Brian Olshansky, M.D., Cardiac Electro-
physiology, University of Iowa Hospitals, 200 Hawkins Drive, Iowa
City, IA 52242. Fax: 319-356-4552; E-mail: brian-olshansky@
uiowa.edu
Manuscript received 7 July 2000; Accepted for publication 13 October
2000.
162
Reprinted with permission from
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Volume 12, No. 2, February 2001
Copyright ©2001 by Futura Publishing Company, Inc., Armonk, NY 10504-0418